Australia markets open in 8 hours 42 minutes

Bausch Health Companies Inc. (BHCN.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
185.000.00 (0.00%)
As of 02:38PM CDT. Market open.
Full screen
Previous close185.00
Open0.00
Bid185.00 x 0
Ask0.00 x 0
Day's range185.00 - 185.00
52-week range185.00 - 438.25
Volume1
Avg. volume20
Market cap65.825B
Beta (5Y monthly)1.62
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022

    Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and disorders, today announced seven posters on behalf of XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® (polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride

  • PR Newswire

    Bausch Health Announces Participation In Upcoming Investor Conferences

    Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in several upcoming investor conferences.

  • PR Newswire

    Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions

    Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb") and Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced the closing of the initial public offering ("IPO") of Bausch + Lomb. A wholly owned subsidiary of Bausch Health (the "Selling Shareholder") sold 35,000,000 common shares at a public offering price of $18.00 per share for aggregate gross proceeds of $630 million, before deducting underwriting commissions and estimated offering expenses. The Selling Shareh